| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,141 |
20,332 |
$895K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,991 |
1,838 |
$83K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,004 |
5,484 |
$52K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,157 |
1,026 |
$43K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,529 |
2,738 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,032 |
958 |
$22K |
| 90832 |
Psychotherapy, 30 minutes with patient |
297 |
283 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
5,892 |
5,287 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
105 |
96 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
393 |
326 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
104 |
101 |
$6K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
89 |
86 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
564 |
522 |
$5K |
| 95115 |
|
406 |
256 |
$4K |
| 90688 |
|
781 |
710 |
$4K |
| 96127 |
|
465 |
322 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,087 |
933 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
12 |
$1K |
| 81002 |
|
690 |
613 |
$1K |
| 87807 |
|
164 |
146 |
$1K |
| 93000 |
|
66 |
65 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$913.96 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
165 |
155 |
$812.82 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
39 |
32 |
$812.59 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$638.60 |
| 3008F |
|
3,225 |
2,866 |
$550.00 |
| 90651 |
|
12 |
12 |
$435.60 |
| 92587 |
|
18 |
17 |
$322.57 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
26 |
12 |
$226.40 |
| 99177 |
|
15 |
13 |
$96.81 |
| 81025 |
|
16 |
14 |
$61.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
165 |
155 |
$15.27 |
| 96160 |
|
17 |
17 |
$8.04 |
| 90461 |
|
156 |
136 |
$0.13 |
| 99499 |
|
15 |
12 |
$0.00 |
| 90686 |
|
41 |
39 |
$0.00 |